Altitude Sickness Drug Appears to Slow Progression of Glioblastoma
Acetazolamide increased sensitivity to treatment and enhanced survival in mice
A drug used to treat altitude sickness — as well as glaucoma, epilepsy, heart failure and seizures — may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma, according to a study.
The drug, acetazolamide, sold under the trade name Diamox, is “cheap to make, easy to take and has limited side effects,” said study director Bahktiar Yamini, MD, a professor of neurosurgery at the University of Chicago Medicine.
“I take it myself, whenever I go to the Rocky Mountains,” he said, “two pills a day.” The most common side effect of Diamox is “a metallic taste when drinking something carbonated.”
The most frequently used chemotherapy for gliomas is a drug called temozolomide (TMZ). However, not all patients respond to this drug. Median survival with this disease is about 14 months.
Click here to read more.
No upcoming events
Be the first to reply using the above form.